Literature DB >> 22932967

Virology of hepatitis D virus.

John M Taylor1.   

Abstract

Although much of the current understanding of the replication of hepatitis D virus (HDV) has been gained from ex vivo rather than in vivo studies, many seemingly unique aspects have been discovered. These include the ultra-small size and circular conformation of the RNA genome, the presence on the viral RNAs of two ribozymes, the role of RNA-directed RNA transcription by redirection of host enzymes, the requirement of site-specific, posttranscriptional RNA-editing, and more. This review addresses recent insights, remaining controversies, and just plain deficits in our understanding of HDV replication. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932967     DOI: 10.1055/s-0032-1323623

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  21 in total

1.  Novel coding, translation, and gene expression of a replicating covalently closed circular RNA of 220 nt.

Authors:  Mounir Georges AbouHaidar; Srividhya Venkataraman; Ashkan Golshani; Bolin Liu; Tauqeer Ahmad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-24       Impact factor: 11.205

2.  A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Authors:  Manabu Kaneko; Koichi Watashi; Shinji Kamisuki; Hiroki Matsunaga; Masashi Iwamoto; Fumihiro Kawai; Hirofumi Ohashi; Senko Tsukuda; Satomi Shimura; Ryosuke Suzuki; Hideki Aizaki; Masaya Sugiyama; Sam-Yong Park; Takayoshi Ito; Naoko Ohtani; Fumio Sugawara; Yasuhito Tanaka; Masashi Mizokami; Camille Sureau; Takaji Wakita
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

Review 3.  Recent breakthroughs in the treatment of chronic hepatitis Delta.

Authors:  Giuseppina Brancaccio; Laura Gaeta; Alessandro Vitale; Giovanni B Gaeta
Journal:  Infez Med       Date:  2022-06-01

Review 4.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

Review 5.  Therapy of Delta Hepatitis.

Authors:  Cihan Yurdaydin; Ramazan Idilman
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

Review 6.  Beyond Metabolism: Role of the Immune System in Hepatic Toxicity.

Authors:  Kenneth L Hastings; Martin D Green; Bin Gao; Patricia E Ganey; Robert A Roth; Gary R Burleson
Journal:  Int J Toxicol       Date:  2020 Mar/Apr       Impact factor: 2.032

Review 7.  In vivo models of hepatitis B and C virus infection.

Authors:  Benjamin Y Winer; Qiang Ding; Jenna M Gaska; Alexander Ploss
Journal:  FEBS Lett       Date:  2016-04-08       Impact factor: 4.124

8.  Current and Future Management of Chronic Hepatitis D.

Authors:  Patrizia Farci; Grazia Anna Niro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-06

9.  High prevalence of hepatitis delta virus among persons who inject drugs, Vietnam.

Authors:  Naomi Hall; Linh Nguyen Thuy; Trinh Do Thi Diem; Allison Waters; Linda Dunford; Jeff Connell; Michael Carr; William Hall; Lan Anh Nguyen Thi
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

Review 10.  Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection.

Authors:  Zhimin Guo; Thomas King
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.